CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading
Top Biotech Companies in Canada Top Biotech Canada Companies - 2024 Top Biotech Canada Companies - 2023 Top Biotech Canada Companies - 2022

Life Sciences Review

Biotech

The Vital Intersection of Academia, Biotech, and Pharma in Producing Medical Therapies

The Vital Intersection of Academia, Biotech, and Pharma in Producing Medical Therapies

Steven Cohen

Executive Director, Translational Medicine-Oncology & Internal Medicine, & Business Development-IM

Daiichi Sankyo, Inc.

Human Health Biotechnology Companies In Canada

Precision Infection Control beyond Antibiotics

Stan Schroeder

President

Zyme Fast

Featured Issue
#

How is Technology Impacting the Biotech Space?

Danielle Portnik, Regional Business Director and International Ambry Genetics
#

Driving innovative therapy for Canadian citizens

Anna Cumaraswamy, Associate Director, Medical Affairs, Oncology Gilead Sciences
#

Technology is Accelerating Change in the Biotech Sector

Elliot Neto, Ruminant Technical Service Manager Kemin Industries
#

Biotechnology should have Preferred Regulatory Pathways to Catalyze the Bioscience Revolution

Lone Dybdal Nilsson, VP of Applied Research in Agriculture and Industrial Bioprocessing Novozymes [NZYM- B]
The digital plant of now Advancing Biopharma Manufacturings Digital Transformation Isnt A One Size Fits All

The digital plant of now Advancing Biopharma Manufacturings Digital Transformation Isnt A One Size Fits All

Nicolas Pivet, VP and GM, Technology Services

Cytiva

The Art and Science of Cannabis-Infused Drinks Using Nanoemulsion Technology

The Art and Science of Cannabis-Infused Drinks Using Nanoemulsion Technology

IIvan A. Salazar, Plant Packaging & Sanitation Manager

Organigram Inc

#

What About Rare Diseases - Canada's National Strategy to Support Innovation and Access

France Lebel, Senior Director Medical Affairs

Recordati [BIT: REC]

News

Clinical Trial Management Moves Toward A More Connected Model

Biomarker Claims Face Evidence Test

Choosing an ADC and AOC CDMO Partner for Complex Bioconjugates

Biomarker Results Leave Decisions Open

The Role of Patient Reported Outcomes to Support Reimbursement and Market Access in Major European Countries and the US

The Role of Patient Reported Outcomes to Support Reimbursement and Market Access in Major European Countries and the US

Lothar Tremmel, Vice President, QCSR (Biometrics + Epidemiology)

CSL Behring

Modular approach for Large Scale Cell Culture CDMO facilities

Modular approach for Large Scale Cell Culture CDMO facilities

Jacob Gronnegaard, Director Automation

FUJIFILM Diosynth Biotechnologies

Making Cell Therapy Accessible to All Patients

Making Cell Therapy Accessible to All Patients

Nuala Trainor, Director of Innovation

Lonza [SWX: LONN]

Microbiological Considerations for Achieving Drug Manufacturing Excellence

Microbiological Considerations for Achieving Drug Manufacturing Excellence

Jessica Wilson Rayse, Assoc Director of Product Management, Accugenix

Charles River Laboratories [NYSE: CRL] [NYSE: CRL]

Aplantex: Universal Access to Active Plant Compounds

Universal Access to Active Plant Compounds

Patrick Charest, CEO

Probiosphere: Harnessing Microbial Power and Enzymatic Solutions for Water Remediation

Harnessing Microbial Power and Enzymatic Solutions for Water Remediation

Pierre Naider Fanfan, President and CEO

Loading...
#

A Venture to Drive Innovations in Near-Patient Testing

Imants Lauks, Founder, Executive Chairman

#

A Premier Incubator of CGT Companies

Dr. Michael May, President and CEO

#

Starpax Magnetodrones™ propel cancer medicine into the future.

Michael Gareau, Founding President and CEO

#

Strengthening Human Immunity with Avian DNA

Alexandre Fugere, Assistant Director of Business Development and Luc Paquet, CEO

A Paradigm Shift in ISF Extraction

A Paradigm Shift in ISF Extraction

George Cagna President and Chief Executive Officer

Uncovering Critical Answers to Combat Rare Diseases

Uncovering Critical Answers to Combat Rare Diseases

Dr. Aneal Khan, Founder, CEO and Medical Director

#

panCELLa-A Pluristyx Company: Accelerating the Development of Advanced Cell Therapies

Jake Krembil, COO of panCELLa and Brian Hawkins, CTO of Pluristyx

News

Driving Efficiency: The Importance of CDMOs in Canada's Pharmaceutical Sector

Commercialization in Human Health Biotechnology Industry in Canada Tends to Be More Complicated

Healthcare Buyers Place Greater Scrutiny on Evidence From Biotechnology Developers

Talent Competition Emerges as a Central Constraint for Canada's Health Biotech Sector

Shaping Drug Development with Medical Glycobiology

Shaping Drug Development with Medical Glycobiology

Dany Valiquette, CEO and Dr. Serge Moffett, Scientific Director

Propelling Cancer Medicine into the Future

Propelling Cancer Medicine into the Future

Michael Gareau, Founding President

Advancing Transplant Biopsy through Objective Diagnostics and Treatment

Advancing Transplant Biopsy through Objective Diagnostics and Treatment

Philip Halloran, CEO, Transcriptome Sciences

Pci - Expanding Its European Biotech Footprint

Pci - Expanding Its European Biotech Footprint

Chris Dobbs, CEng MIET, Head of Technical Engineering, PCI Pharma Services

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://biotech-canada.lifesciencesreview.com